Table 1.
Patient characteristics.
| All patients | D-dimer ≤14,500 ng/ml | D-dimer >14,500 ng/ml | p -value | |
|---|---|---|---|---|
| (n = 470) | (n = 273) | (n = 197) | ||
| Demographics | ||||
| Age (years) | 51.86 ± 10.76 | 50.39 ± 11.36 | 54.24 ± 9.52 | <0.001 |
| Male gender | 396 (84.26%) | 227 (83.15%) | 169 (85.79%) | 0.439 |
| Smoker | 161 (34.26%) | 98 (35.90%) | 63 (31.98%) | 0.337 |
| Drinker | 35 (7.45%) | 17 (6.23%) | 18 (9.14%) | 0.236 |
| BMI (Kg/m2) | 24.79 ± 3.94 | 24.65 ± 3.97 | 24.75 ± 3.96 | 0.511 |
| Medical history | ||||
| Hypertension | 321 (68.30%) | 153 (64.8%) | 168 (71.8%) | 0.105 |
| Diabetes | 8 (1.7%) | 5 (1.83%) | 3 (1.52%) | 0.799 |
| History of cardiovascular surgery | 37 (7.87%) | 34 (12.45%) | 3 (1.52%) | <0.001 |
| CAD | 46 (9.79%) | 25 (9.15%) | 21 (10.66%) | 0.589 |
| MFS | 24 (5.11%) | 20 (7.33%) | 4 (2.03%) | 0.010 |
| BAV | 10 (2.16%) | 9 (3.30%) | 1 (0.51%) | 0.039 |
| Aspirin | 11 (2.34%) | 7 (2.56%) | 4 (2.03%) | 0.706 |
| Admission laboratory results | ||||
| White blood cell count (×109) | 12.48 (10.22–15.20) | 11.52 (9.43–13.97) | 13.77 (11.61–16.38) | <0.001 |
| Neutrophil ratio | 0.822 (0.757–0.861) | 0.785 (0.723–0.835) | 0.849 (0.808–0.886) | <0.001 |
| Platelets (×109) | 185 (151–228) | 202 (164–253) | 164 (131–200) | <0.001 |
| D-dimer (ng/ml) | 10,120 (3,450–20,000) | 4,160 (1,590–8,070) | 20,000 (20,000–20,000) | <0.001 |
| Echocardiographic | ||||
| LVEF | 63.80 ± 6.41 | 63.43 ± 6.55 | 64.31 ± 6.19 | 0.147 |
| AAO | 43.64 ± 7.22 | 44.09 ± 7.95 | 43.02 ± 6.02 | 0.116 |
| LA | 34.12 ± 4.95 | 34.39 ± 4.90 | 33.73 ± 5.00 | 0.160 |
| LVESD | 30.23 ± 5.96 | 31.40 ± 2.25 | 29.01 ± 5.58 | <0.001 |
| AR | 0.160 | |||
| None/mild | 313 (66.60%) | 181 (66.30%) | 132 (67.01%) | |
| Moderate | 88 (18.72%) | 47 (17.22%) | 41 (20.81%) | |
| Severe | 61 (12.98%) | 40 (14.65%) | 21 (10.66%) | |
| MR | 0.111 | |||
| None/mild | 442 (97.04%) | 256 (93.77%) | 189 (95.94%) | |
| Moderate | 13 (2.77%) | 10 (3.66%) | 3 (1.52%) | |
| Severe | 3 (0.64%) | 2 (0.73%) | 1 (0.51%) | |
| TR | 0.855 | |||
| None/mild | 435 (92.5%) | 251 (91.94%) | 184 (93.40%) | |
| Moderate | 22 (4.68%) | 14 (5.13%) | 8 (4.06%) | |
| Severe | 4 (0.85%) | 3 (1.10%) | 1 (0.51%) | |
| Procedural information | ||||
| CPB time | 241.0 (211.0–280.0) | 234.0 (202.0–265.0) | 258.0 (217.5–296.5) | <0.001 |
| ACC time | 132.0 (103.0–160.0) | 132.0 (103.0–160.0) | 127.0 (101.0–151.0) | <0.001 |
| CABG | 32 (6.81%) | 12 (4.40%) | 20 (10.15%) | 0.014 |
| Total arch replacement | 452 (96.17%) | 256 (93.77%) | 196 (99.49%) | 0.001 |
Smoker is defined as current smoker (smoke more than 100 cigarettes and has smoked in the last 1 month) and ex-smoker.
BMI, body mass index; BAV, bicuspid aortic valve; MFS, Marfan syndrome; CAD, coronary artery disease; LVEF, left ventricular ejection fraction; AAO, ascending arota; LA, left atrium; LVESD, left ventricular end diastolic diameter; AR, aorta ascendens; MR, mitral regurgitation; TR, tricuspid regurgitation; CPB, cardiopulmonary bypass; ACC, aortic cross clamp; CABG, coronary artery bypass graft.